AHF Hammers Gilead Over Continued Profiteering
AIDS Healthcare Foundation (AHF) continued its assault on Gilead Sciences in its ongoing advocacy campaign against the Bay Area drug maker over its voracious greed, patent manipulation, and obscene price hikes.
- AIDS Healthcare Foundation (AHF) continued its assault on Gilead Sciences in its ongoing advocacy campaign against the Bay Area drug maker over its voracious greed, patent manipulation, and obscene price hikes.
- “Gilead continues to place profit above all else at the expense of patients’ access to its lifesaving drugs, including its latest and safest drug formulations,” says Michael Weinstein, AHF president and cofounder.
- “From suppressing a safer formulation of one of its key HIV drugs to price gouging on its Hepatitis C medications, Gilead remains a company in search of a moral compass.
- To learn more about AHF, visit us online at AIDShealth.org , find us on Facebook , follow us on Instagram , Twitter , and TikTok , and subscribe to our AHFter Hours podcast.